1-1 of 1
parp1 protein
Close
Sort by
Journal Articles

MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugs

Silvia Maifrede, Esteban Martinez, Margaret Nieborowska-Skorska, Daniela Di Marcantonio, Michael Hulse, Bac Viet Le, Huaqing Zhao, Katarzyna Piwocka, Italo Tempera, Stephen M. Sykes, Tomasz Skorski
Journal: Blood Advances
Blood Adv (2017) 1 (19): 1467–1472.
https://doi.org/10.1182/bloodadvances.2017006247
Published: 2017
Includes: Supplemental data